PR1 is a HLA-A2 restricted leukemia-associated peptide from proteinase 3 (P3) and neutrophil elastase (NE) recognized by anti-PR1-specific cytotoxic T lymphocytes which can contribute to cytogenetic remission of AML. The gene discussed is TMEM37; the disease is leukemia.